Search

Today’s recommendation is a medical device company whose one product—an insulin delivery system for diabetics—is growing market share rapidly.

In tonight’s issue, we dive into some education, revealing a long-term chart pattern that bodes well (including one stock that’s at the top of our Watch List now). We also give you all our latest thoughts on the market and our recommended stocks, and present the usual crop of new ideas if you have some cash on the sideline.

We’ve pared back during the past few days in the Model Portfolio, but we\'re not sticking our heads in the sand and are giving our profitable stocks room to consolidate. In tonight’s issue, we dive into our game plan for our remaining stocks, and we also do some sector analysis, including two areas that are launching new leaders.

The major indexes have been flopping around this week, with some ups and downs, though things are quieting down just a bit. Growth funds have been mostly in the same boat, choppy but up a smidge on the week. Not the worst, not the best.

Current Market Outlook


During the last couple of weeks of August, more stocks, sectors and indexes were getting in gear, which was a change from the past few months of whippy crosscurrents. But as September has progressed, it looks like we’re still in the same overall environment—growth stocks, indexes and funds have again taken hits while some cyclical/value areas have perked up. That’s not necessarily a negative (at least to this point); as we wrote last week, some retrenchment among extended growth stocks was half-expected, and even if it wasn’t, the action is more a confirmation that the choppy environment is still intact, not that the sellers are truly taking control. Long story short, we’re still sticking with the same game plan as the evidence remains unchanged—we’re more bullish than not, but booking partial profits into strength, raising stops as things head higher and aiming to enter on dips is the right way to go.

This week’s list is lighter on growth stocks than in recent weeks, reflecting some of the dents they’re taking, but there are many other names that look to be resuming their advances. Our Top Pick is Antero Resources (AR), which looks like the best play in the natural gas space. Aim to enter on dips.

Stock Name	Price	Buy Range	Loss Limit
Antero Resources (AR)	17	15.4-16.1	13.8-14.2
Celsius Holdings (CELH)	87	84-88	73.5-75.5
DOCN (DOCN)	76	69-73	58-60
ICU Medical (ICUI)	240	233-243	215-220
Innovative Industrial Properties (IIPR)	228	222-230	209-212
MongoDB (MDB)	485	460-475	408-420
Pure Storage (PSTG)	26	25-26	22.5-23
SBLK (SBLK)	24	23-24.5	19.5-20.5
Teck Resources Limited (TECK)	25	23.5-24.5	21.5-22
Varonis Systems (VRNS)	68	65.5-68	59-60

We’re officially in a bear market, but this options strategy can help you take advantage of higher premiums and make profitable trades.

Tech stocks have taken it on the chin for much of this year, but that’s turned these tech stalwarts into high-yielding bargains.

Cannabis legalization is spreading but cannabis stocks are trading near all-time lows, which leaves these four industry leaders poised for a rebound.

With 10,000 micro-cap stocks in the U.S. and Canada, it’s easy for the market to miss investments with a lot of potential. Here are three I like right now.

You may not be familiar with market anomalies, but one type in particular regularly outperforms the market, at times by as much as 5-to-1.

Instead of simply trying to wait out this bear market, consider adding inverse ETFs to your portfolio to boost and smooth your returns.

Small-cap stocks have been lagging their larger peers for months, is that enough to make them bullish in this bear?

Dividend Kings are stocks with long-established histories of paying and increasing their dividends, here are my three favorite right now.

The investing environment is tough, and macro events are largely outside of our control, so keep these tips in mind to preserve both capital and sanity in the turbulent market.

A strong dollar has helped cap some inflationary pressures in the U.S., but with the arrival of volatility in currencies you should consider these investments as hedges against an uncertain dollar.